Trexquant Investment’s Belite Bio BLTE Stock Holding History
Bought
Maintained
Sold
Other funds holding BLTE
DGM
Trexquant Investment's BLTE Position: Q3 2026 in Review
Trexquant Investment reduced its Belite Bio (BLTE) stake by 16% in Q3 2026, selling an estimated $1.25M and leaving 41,788 shares worth $7.1M. The position accounts for 0.04% of the portfolio, ranked #612.
Trexquant Investment first reported a position in BLTE in Q1 2026 and has held it in 3 quarters since. The position peaked at $7.62M in Q2 2026. 96 funds tracked by Wall St. Rank hold BLTE as of Q3 2026.
- Trexquant Investment held 41,788 shares of Belite Bio worth $7.1M as of Q3 2026.
- Trexquant Investment sold 7,728 Belite Bio shares in Q3 2026, an estimated $1.25M.
- Belite Bio made up 0.04% of Trexquant Investment's portfolio in Q3 2026, its #612 holding.
- Trexquant Investment first reported a position in Belite Bio in Q1 2026 and has held it in 3 quarters since.
- Trexquant Investment's Belite Bio position peaked at $7.62M in Q2 2026.
- 96 funds tracked by Wall St. Rank held Belite Bio as of Q3 2026.
Based on Trexquant Investment's 13F filing for Q3 2026, filed 16 Nov 2026.